- Discovery Project
- Wilsede Meetings
- Special Lectures and Interviews
- St. Petersburg Meetings
- 20. International Leukemia Workshop
- Introductions
- Lectures: Overview and slides
- B. Gale: Discovery of BCR-ABL
- B. Gale: Nuclear accidents: Chernobyl and Fukushima: What do they mean?
- C. Bloomfield: Prognostic impact of karyotype in AML
- C. Haferlach: Aneuploidy in leukemia
- K. Welte: Isolation of G-CSF
- R. Kurth: Beneficial and detrimental effects of human endogenous retroviruses
- R. Mertelsmann: G-CSF in clinical practice
- Dinner at Schwetzinger Schloss
- Emergency Medicine
- Various
Lectures
20th International Leukemia-Workshop
Jubilee Workshop
July 1 - 3, 20 11
Medizinische Fakultät Mannheim der Universität Heidelberg, Hörsaal 1, Haus 6, Ebene 4
Mannheim, Germany
Memorizes the 625. anniversary of Heidelberg University
Organization: German CML Study Group - Prof. Dr. Rüdiger Hehlmann, Mannheim
Saturday, July 2, 2011
17.30 - 17.45 h
From basics to clinical application - 40 years Wilsede and IACRLRD* Leukemia-Meetings
R. Hehlmann, C. Bloomfield
17.45 - 19.25 h
Session 1: From detection of G-CSF and BCR-ABL to application in clinical practice
Chair: R. Neth, W. K. Hofmann
17.45 - 18.05 h
Basics
K. Welte, M. Moore, (Hannover/Germany, New York/USA)
Isolation of G-CSF
18.05 - 18.25 h
Clinical translation
R. Mertelsmann, (Freiburg/Germany)
G-CSF in clinical practice
18.35 - 18.55 h Basics
B. Gale, (Los Angeles/USA)
Discovery of BCR-ABL
18.55 - 19.15 h Clinical translation
J. Goldman
(London/United Kingdom)
BCR-ABL inhibition in clinical practice
Sunday
09.00 - 10.30 h
Session 2: From identification of aneuploidy and MRD to management of leukemia
Chair: D. Hoelzer, A. Ho
09.00 - 09.20 h Basics
C. Haferlach, (München/Germany)
Aneuploidy in leukemia
09.20 - 09.40 h
Clinical translation
C. Bloomfield, (Columbus/USA)
Prognostic impact of karyotype in AML
(Handout pdf )
09.40 - 10.00 h Basics
J. van Dongen, (Rotterdam/The Netherlands)
MRD diagnostics
(Handout - pdf - )
10.00 - 10.20 h
Clinical translation
D. Hoelzer, (Frankfurt/Germany)
MRD – directed therapy of ALL
10.30 - 11.00 h Coffee break
11.00 - 12.30 h Session 3:
From detection of human retroviruses to an AIDS vaccine and management of acute T-cell leukemia
Chair: R. Gallo, L. Chieco-Bianchi
11.00 - 11.20 h Basics // to be canceled
R. Gallo, (Baltimore/USA)
Search for human leukemia viruses and isolation of HTLV1 and HIV
11.20 - 11.40 h Basics
R. Kurth, (Berlin/Germany)
Beneficial and detrimental effects of human endogenous retroviruses
(slides -pdf- )
11.40 - 12.00 h Clinical translation
V. Erfle, (München/Germany)
Vaccination against AIDS (slides - pdf)
12.00 - 12.20 h Clinical translation
A. Bazarbachi, (Beirut/Lebanon)
Management of ATL (slides - pdf)
12.30 - 12.50 h Special lecture
R. Gale, (Los Angeles/USA)
Nuclear accidents: Chernobyl and Fukushima: What do they mean?